By Stephanie Murg, Managing Director, G2 Intelligence
To report or not to report to patients? That is the question when it comes to genetic variations, largely single-nucleotide polymorphisms, found by large-scale DNA sequencing to be associated with common medical conditions. A new study that used electronic medical records (EMRs) to evaluate the clinical validity of…
Read more...
By Kelly A. Briganti, Editorial Director, G2 Intelligence
The International School of Biomedical Diagnostics (ISBD) at Arizona State University (ASU) recently invited companies in biomedical diagnostics and affiliated fields to partner with ISBD on research projects addressing issues in the diagnostics industry. Industry partners will benefit from…
Read more...
By Ron Shinkman, Editor, Laboratory Industry Report
Transplant Genomics has announced it has entered into deals with four hospitals and health care systems to use its assay for kidney transplant recipients. California Pacific Medical Center in San Francisco, Henry Ford Health System in Detroit, Houston Methodist Hospital and…
Read more...
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies
Next-generation-based sequencing panels for hereditary cancer risk yield high frequency of positive results in both cancer genes tied to clinical care guidelines, as well as those with less well characterized penetrance, according to a study published online Dec. 17, 2015 in Genetics in Medicine. While not all patients or providers are…
Read more...
|
